0.75% phentolamine ophthalmic solution

DRUG2 trials

Sponsors

Ocuphire Pharma, Inc.

Conditions

PresbyopiaVision DisordersVision Loss Night

Phase 3

Evaluate Efficacy and Safety of POS to Improve Distance-corrected Near Visual in Participants With Presbyopia

CompletedNCT06542497

Ocuphire Pharma, Inc.Presbyopia

Start: 2024-08-15End: 2026-01-22Updated: 2026-08-17

OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity

RecruitingNCT07140783

Ocuphire Pharma, Inc.Vision Disorders, Vision Loss Night

Start: 2025-09-02End: 2027-08-01Target: 580Updated: 2026-09-08